Mesoblast Limited Financial Overview
Mesoblast Limited's market cap is currently $3.62B. The company's EPS TTM is AU$-0.06444023171999999; its P/E ratio is ―; Mesoblast Limited is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is AU$-0.01. See an overview of income statement, balance sheet, and cash flow financials.
